Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Original Paper
  • Published:

Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation

Abstract

The E6 proteins from the high-risk human papillomavirus (HPV) types have previously been shown to target a number of PDZ domain-containing proteins for proteasome-mediated degradation. These include the hDlg tumour suppressor and the MAGI-1 protein. In this study we show that high-risk HPV E6 proteins also target the related MAGI-2 and MAGI-3 proteins for degradation. Moreover, we show that the interaction is specific to one PDZ domain, and that co-expression of this domain can protect each of the full-length MAGI proteins from E6-mediated degradation. These data provide clear indicators for the potential design of compounds that could specifically inhibit the interaction of oncogenic HPV E6 proteins with an important class of target proteins.

This is a preview of subscription content, access via your institution

Access options

Rent or buy this article

Prices vary by article type

from$1.95

to$39.95

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7

Similar content being viewed by others

References

  • Adey NB, Huang L, Ormonde PA, Baumgard ML, Pero R, Byreddy DV, Tavtigian SV, Bartel PL . 2000 Cancer Res. 60: 35–37

  • Androphy E, Hubbert N, Schiller J, Lowy D . 1987 EMBO J. 6: 989–992

  • Banks L, Matlashewski G, Crawford L . 1986 Eur. J. Biochem. 159: 529–534

  • Banks L, Spence P, Androphy E, Hubbert N, Matlashewski G, Murray A, Crawford L . 1987 J. Gen. Virol. 68: 1351–1359

  • Bilder D, Li M, Perrimon N . 2000 Science 289: 113–116

  • Cho KO, Hunt CA, Kennedy MB . 1992 Neuron 9: 929–942

  • Choi J, Ko J, Park E, Lee J-R, Yoon J, Lim S, Kim E . 2002 J. Biol. Chem. 277: 12359–12363

  • Craven SE, Bredt DS . 1998 Cell 93: 495–498

  • Dobrosotskaya IY . 2001 Biochem. Biophys. Res. Commun. 283: 969–975

  • Dobrosotskaya IY, James GL . 2000 Biochem. Biophys. Res. Commun. 270: 903–909

  • Dobrosotskaya I, Guy RK, James GL . 1997 J. Biol. Chem. 272: 31589–31597

  • Downward J . 1998 Curr. Opin. Cell Biol. 10: 262–267

  • Doyle DA, Lee A, Lewis J, Kim E, Sheng M, MacKinnon R . 1996 Cell 85: 1067–1076

  • Fanning AS, Anderson JM . 1999 J. Clin. Invest. 103: 767–772

  • Franco EL . 1992 Cancer Epidemiol. Biomarkers Prev. 1: 499–504

  • Gardiol D, Kühne C, Glaunsinger B, Lee S, Javier R, Banks L . 1999 Oncogene 18: 5487–5496

  • Georgescu MM, Kirsch KH, Akagi T, Shishido T, Hanafusa H . 1999 Proc. Natl. Acad. Sci. USA 96: 10182–10187

  • Glaunsinger B, Lee S, Thomas M, Banks L, Javier R . 2000 Oncogene 19: 5270–5280

  • Gomperts SN . 1996 Cell 84: 659–662

  • Ide N, Hata Y, Nishioka H, Hirao K, Yao I, Deguchi M, Mizoguchi A, Nishimori H, Tokino T, Nakamura Y, Takai Y . 1999 Oncogene 18: 7810–7815

  • Kim E, DeMarco SJ, Marfatia SM, Chishti AH, Sheng M, Strehler EE . 1998 J. Biol. Chem. 273: 1591–1595

  • Kim SK . 1997 Curr. Opin. Cell Biol. 9: 853–859

  • Kiyono T, Hiraiwa A, Fujita M, Hayashi Y, Akiyama T, Ishibashi M . 1997 Proc. Natl. Acad. Sci. USA 94: 11612–11616

  • Kühne C, Gardiol D, Guarnaccia C, Amenitsch H, Banks L . 2000 Oncogene 19: 5884–5891

  • Lee SS, Weiss RS, Javier RT . 1997 Proc. Natl. Acad. Sci. USA 94: 6670–6675

  • Leslie NR, Gray A, Pass I, Orchiston EA, Downes CP . 2000 Biochem. J. 346: 827–833

  • Leslie NR, Bennett D, Gray A, Pass I, Hoang-Xuan K, Downes CP . 2001 Biochem. J. 357: 427–435

  • Li J, Simpson L, Takahashi M, Miliaresis C, Myers MP, Tonks N, Parsons R . 1998 Cancer Res. 56: 5667–5672

  • Mantovani F, Banks L . 2001 Oncogene 20: 7874–7887

  • Mantovani F, Massimi P, Banks L . 2001 J. Cell Sci. 114: 4285–4292

  • Marte B, Downward J . 1997 Trends Biochem. Sci. 22: 355–358

  • Mitic LL, Anderson JM . 1998 Annu. Rev. Physiol. 60: 121–142

  • Morais Cabral JH, Petosa C, Sutcliffe MJ, Raza S, Byron O, Poy F, Marfatia SM, Chishti AH, Liddington RC . 1996 Nature 382: 649–652

  • Nakagawa S, Huibregtse J . 2000 Mol. Cell. Biol. 21: 8244–8253

  • Pim D, Storey A, Thomas M, Massimi P, Banks L . 1994 Oncogene 9: 1869–1876

  • Pim D, Thomas M, Javier R, Gardiol D, Banks L . 2000 Oncogene 19: 719–725

  • Pim D, Thomas M, Banks L . 2001 Viruses, Cell Transformation and Cancer Grand RJA (ed.) Amsterdam: Elsevier pp. 145–192

    Book  Google Scholar 

  • Polakis P . 1999 Curr. Opin. Genet. Dev. 9: 15–21

  • Ponting C, Phillips C . 1995 Trends Biochem. Sci. 20: 102–103

  • Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM, Zon LI . 1994 Nature 372: 794–798

  • Saras J, Heldin C . 1996 Trends Biochem. Sci. 21: 455–458

  • Scheffner M, Werness B, Huibregtse J, Levine A, Howley P . 1990 Cell 63: 1129–1136

  • Shoji H, Tsuchida K, Kishi H, Yamakawa N, Matsuzaki T, ZhongHui L, Nakamura T, Sugino H . 2000 J. Biol. Chem. 275: 5485–5492

  • Songyang Z, Fanning AS, Fu C, Xu J, Marfatia SM, Chisti AH, Crompton A, Chan AC, Anderson JM, Cantley LC . 1997 Science 275: 73–77

  • Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, Ruland J, Penninger JM, Siderovski DP, Mak TW . 1998 Cell 95: 29–39

  • Thomas M, Banks L . 1998 Oncogene 17: 2943–2954

  • Thomas M, Pim D, Banks L . 1999 Oncogene 18: 7690–7700

  • Thomas M, Glaunsinger B, Pim D, Javier R, Banks L . 2001 Oncogene 20: 5431–5439

  • Tolkacheva T, Chan AM . 2000 Oncogene 19: 680–689

  • Tolkacheva T, Boddapati M, Sanfiz A, Tsuchida K, Kimmelman AC, Chan AM . 2001 Cancer Res. 61: 4985–4989

  • Torres J, Pulido R . 2001 J. Biol. Chem. 276: 993–998

  • Vazquez F, Ramaswamy S, Nakamura N, Sellers WR . 2000 Mol. Cell. Biol. 20: 5010–5018

  • Wigler M, Sweet R, Sim GK, Wold B, Pellicer A, Lacy E, Maniatis T, Silverstein S, Axel R . 1979 Cell 16: 777–785

  • Wood JD, Yuan J, Margolis RL, Colomer V, Duan K, Kushi J, Kaminsky Z, Kleiderlein Jr JJ, Sharp AH, Ross CA . 1998 Mol. Cell. Neuroscience 11: 149–160

  • Wu X, Hepner K, Castelino-Prabhu S, Do D, Kaye MB, Yuan X-J, Wood J, Ross C, Sawyers CL, Whang YE . 2000a Proc. Natl. Acad. Sci. USA 97: 4233–4238

  • Wu Y, Dowbenko D, Spencer S, Laura R, Lee J, Gu Q, Laskey L . 2000b J. Biol. Chem. 275: 21477–21485

Download references

Acknowledgements

The authors would like to thank Dr Oliviero Carugo for useful discussions. This work was supported in part by grants from the National Institutes of Health, the Department of Defense and CapCURE to C Sawyers and a grant from the Associazione Italiana per la Ricerca sul Cancro to L Banks.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Lawrence Banks.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Thomas, M., Laura, R., Hepner, K. et al. Oncogenic human papillomavirus E6 proteins target the MAGI-2 and MAGI-3 proteins for degradation. Oncogene 21, 5088–5096 (2002). https://doi.org/10.1038/sj.onc.1205668

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.onc.1205668

Keywords

This article is cited by

Search

Quick links